Filing Details

Accession Number:
0001209191-14-009881
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-12 18:31:05
Reporting Period:
2014-02-10
Filing Date:
2014-02-12
Accepted Time:
2014-02-12 18:31:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1454189 Auspex Pharmaceuticals Inc. ASPX Pharmaceutical Preparations (2834) 954862842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405712 Cmea Ventures Vii Lp One Letterman Drive
Building C, Suite Cm500
San Francisco CA 94129
No No Yes No
1405972 Cmea Ventures Vii (Parallel) Lp One Letterman Drive
Building C, Suite Cm500
San Francisco CA 94129
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-10 3,670,065 $0.00 3,670,065 No 4 C Direct
Common Stock Acquisiton 2014-02-10 102,873 $12.00 3,772,938 No 4 P Direct
Common Stock Acquisiton 2014-02-10 94,103 $0.00 94,103 No 4 C Indirect By CMEA Ventures VII (Parallel), L.P.
Common Stock Acquisiton 2014-02-10 2,688 $12.00 96,796 No 4 P Indirect By CMEA Ventures VII (Parallel), L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
No 4 C Indirect By CMEA Ventures VII (Parallel), L.P.
No 4 P Indirect By CMEA Ventures VII (Parallel), L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2014-02-10 1,635,551 $0.00 363,456 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2014-02-10 5,394,437 $0.00 1,198,764 $0.00
Common Stock Series D Convertible Preferred Stock Disposition 2014-02-10 8,510,898 $0.00 1,891,310 $0.00
Common Stock Series E Convertible Preferred Stock Disposition 2014-02-10 1,397,873 $0.00 310,638 $0.00
Series C Preferred Stock Preferred Stock Warrant Disposition 2014-02-10 211,629 $0.00 211,629 $0.86
Common Stock Common Stock Warrant Acquisiton 2014-02-10 47,028 $0.00 47,028 $3.88
Series C Preferred Stock Preferred Stock Warrant Disposition 2014-02-10 193,348 $0.00 193,348 $0.86
Common Stock Common Stock Warrant Acquisiton 2014-02-10 42,966 $0.00 42,966 $3.88
Series C Preferred Stock Preferred Stock Warrant Disposition 2014-02-10 190,535 $0.00 190,535 $0.86
Common Stock Common Stock Warrant Acquisiton 2014-02-10 42,340 $0.00 42,340 $3.88
Series D Preferred Stock Preferred Stock Warrant Disposition 2014-02-10 545,243 $0.00 545,243 $0.86
Common Stock Common Stock Warrant Acquisiton 2014-02-10 121,165 $0.00 121,165 $3.88
Series D Preferred Stock Preferred Stock Warrant Disposition 2014-02-10 290,022 $0.00 290,022 $0.86
Common Stock Common Stock Warrant Acquisiton 2014-02-10 64,449 $0.00 64,449 $3.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 2014-05-22 No 4 C Indirect
47,028 2014-05-22 No 4 C Indirect
0 2014-10-09 No 4 C Indirect
42,966 2014-10-09 No 4 C Indirect
0 2015-01-08 No 4 C Indirect
42,340 2015-01-08 No 4 C Indirect
0 2016-12-15 No 4 C Indirect
121,165 2016-12-15 No 4 C Indirect
0 2017-07-18 No 4 C Indirect
64,449 2017-07-18 No 4 C Indirect
Footnotes
  1. Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 4.5 shares of preferred stock converted into one share of common stock.
  2. The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.
  3. The securities are held as follows: 354,370 shares by CMEA Ventures VII, L.P. ("CMEA") and 9,086 shares by CMEA Ventures VII (Parallel), L.P. ("CMEA (Parallel)").
  4. The securities are held by CMEA and CMEA (Parallel), as described in column 7.
  5. The securities are held as follows: 1,168,795 shares by CMEA and 29,969 shares by CMEA (Parallel).
  6. The securities are held as follows: 1,844,028 shares by CMEA and 47,282 shares by CMEA (Parallel).
  7. The securities are held as follows: 308,872 shares by CMEA and 7,766 shares by CMEA (Parallel).
  8. Automatic conversion, in connection with the Issuer's initial public offering, of warrants to purchase Convertible Preferred Stock into warrants to purchase Common Stock. The warrants converted at a rate of 4.5 shares of Preferred Stock to 1 share of Common Stock.
  9. The warrant is immediately exercisable.
  10. The securities are held as follows: 206,339 shares by CMEA and 5,290 shares by CMEA (Parallel).
  11. The securities are held as follows: 45,853 shares by CMEA and 1,175 shares by CMEA (Parallel).
  12. The securities are held as follows: 188,515 shares by CMEA and 4,833 shares by CMEA (Parallel).
  13. The securities are held as follows: 41,892 shares by CMEA and 1,074 shares by CMEA (Parallel).
  14. The securities are held as follows: 185,772 shares by CMEA and 4,763 shares by CMEA (Parallel).
  15. The securities are held as follows: 41,282 shares by CMEA and 1,058 shares by CMEA (Parallel).
  16. The securities are held as follows: 531,612 shares by CMEA and 13,631 shares by CMEA (Parallel).
  17. The securities are held as follows: 118,136 shares by CMEA and 3,029 shares by CMEA (Parallel).
  18. The securities are held as follows: 282,772 shares by CMEA and 7,250 shares by CMEA (Parallel).
  19. The securities are held as follows: 62,838 shares by CMEA and 1,611 shares by CMEA (Parallel).